PAR4 antagonist 7

PAR4 antagonist 7 (Compound 20f) is selective PAR4 antagonist (IC50: 1.72 nM) . PAR4 antagonist 7 inhibits PAR4 agonist-induced platelet aggregation. PAR4 antagonist 7 has good metabolic stability. PAR4 antagonist 7 does not show a bleeding tendency in mice[1].

Product Specifications

UNSPSC

12352005

Target

Protease Activated Receptor (PAR)

Type

Reference compound

Related Pathways

GPCR/G Protein

Applications

Neuroscience-Neuromodulation

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/par4-antagonist-7.html

Smiles

COC1=NC2=CC(C)=CC(C3=NC4=C(S3)C(C[C@@H](O5)COC(NC6=CC=CC(C#N)=C6)=O)=C5C(F)=C4)=C2C=N1

Molecular Formula

C28H20FN5O4S

Molecular Weight

541.55

References & Citations

[1]Li S, et al. Discovery of quinazoline-benzothiazole derivatives as novel potent protease-activated receptor 4 antagonists with improved pharmacokinetics and low bleeding liability. Eur J Med Chem. 2024 Dec 15;280:116980.